Overview

Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A

Status:
Completed
Trial end date:
2020-05-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the antiviral effect, as measured by the time to alleviation of influenza symptoms and viral titer in nasopharyngeal secretions in adults with acute uncomplicated influenza A following administration of ZSP1273.
Phase:
Phase 2
Details
Lead Sponsor:
Guangdong Raynovent Biotech Co., Ltd